ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00440128
Recruitment Status : Completed
First Posted : February 26, 2007
Last Update Posted : August 4, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline